View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Ophthalmology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 15, 2023
27 min listen
Save

Conversation with Gil Kliman, MD, about Silicon Valley Bank

Conversation with Gil Kliman, MD, about Silicon Valley Bank

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the Silicon Valley Bank collapse and its impact on investing and innovation in the field of ophthalmology with Gilbert H. Kliman, MD.

SPONSORED CONTENT
January 27, 2023
33 min listen
Save

Wearing multiple hats: How to multitask and balance career paths outside of clinical practice

Wearing multiple hats: How to multitask and balance career paths outside of clinical practice

Dagny Zhu, MD, Cathleen M. McCabe, MD, and Laura M. Periman, MD, talk with Cynthia A. Matossian, MD, FACS, about the multitude of career pathways in ophthalmology and balancing career with family.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
January 19, 2023
2 min read
Save

Overall risk for hydroxychloroquine retinopathy low, increases with higher doses

Overall risk for hydroxychloroquine retinopathy low, increases with higher doses

The overall risk for incident retinopathy in patients who received hydroxychloroquine for 5 or more years was low but progressively increased with higher doses, according to researchers.

SPONSORED CONTENT
December 01, 2022
2 min read
Save

Positive results announced from phase 2 trial of oral MS therapeutic

Positive results announced from phase 2 trial of oral MS therapeutic

Clinical-stage biopharmaceutical company Clene Inc. announced proof-of-concept evidence of potential neuroprotective effects of CNM-Au8, an oral therapeutic for patients with stable relapsing-remitting MS.

SPONSORED CONTENT
November 15, 2022
2 min read
Save

Inebilizumab reduces B-cell subsets in neuromyelitis optica spectrum disorder attacks

Inebilizumab reduces B-cell subsets in neuromyelitis optica spectrum disorder attacks

Treatment with inebilizumab was associated with reduction in aquaporin-4 antibody titers and B cells for those with neuromyelitis optica spectrum disorder, according to an expert at ECTRIMS 2022.

SPONSORED CONTENT
October 31, 2022
2 min read
Save

App-based assessment tool may be useful for rapid sideline concussion diagnosis

App-based assessment tool may be useful for rapid sideline concussion diagnosis

CHICAGO – An app-based cognitive assessment tool set baseline scores for college football players and may be useful in rapid sideline concussion diagnosis, according to a poster at the 2022 American Neurological Association meeting.

SPONSORED CONTENT
October 27, 2022
2 min read
Save

New model may help assess chronic uveitis risk in juvenile idiopathic arthritis

New model may help assess chronic uveitis risk in juvenile idiopathic arthritis

A validated prognostic tool using common clinical markers could help clinicians evaluate patients with juvenile idiopathic arthritis for chronic uveitis risk, according to data published in Arthritis & Rheumatology.

SPONSORED CONTENT
October 13, 2022
1 min read
Save

Amydis launches phase 1/2a trial to evaluate novel retinal tracer in patients with ALS, PD

Amydis launches phase 1/2a trial to evaluate novel retinal tracer in patients with ALS, PD

Amydis Inc. announced that patient enrollment in underway for a phase 1/2a trial to evaluate AMDXP-2011P, a retinal imaging agent that targets protein biomarkers in patients with Parkinson’s disease and ALS.

SPONSORED CONTENT
September 27, 2022
12 min listen
Save

Dr. Mali’s AAO 2022 Annual Meeting Hot Topics Preview

Dr. Mali’s AAO 2022 Annual Meeting Hot Topics Preview

In this episode, I share my preview of the hot topics for the upcoming AAO 2022 annual meeting, including my thoughts on ocular gene therapy and new treatments in the works.

SPONSORED CONTENT
September 26, 2022
26 min listen
Save

Women in Business: An Interview with FIGS' Heather Hasson and Trina Spear

Women in Business: An Interview with FIGS' Heather Hasson and Trina Spear

Dagny Zhu, MD, talks with Trina Spear and Heather Hasson, co-founders and co-CEOs of FIGS Scrubs, about they help female physicians feel confident and perform their best, their initiatives to celebrate healthcare workers and address gender disparities in the medical workforce and more.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails